<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1446">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 08, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04682912</url>
  </required_header>
  <id_info>
    <org_study_id>MersinTRH</org_study_id>
    <nct_id>NCT04682912</nct_id>
  </id_info>
  <brief_title>Blood Types in Children With COVID-19</brief_title>
  <official_title>ABO-Rh Blood Types and COVID-19 Infection in Children: Is There a Link?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mersin Training and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Mersin University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Dicle University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Bezmialem Vakif University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Uludag University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Mersin Training and Research Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      It is speculated that in adult patients with COVID-19 blood type A is associated with the&#xD;
      worst outcome, while blood type O is associated with mild symptoms.To our knowledge, there&#xD;
      has been no such a study investigated ABO and Rhesus (Rh) blood group types in children with&#xD;
      COVID-19 infection yet. Therefore, the study aimed to examine if such a correlation exists in&#xD;
      children infected with COVID-19.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 30, 2021</start_date>
  <completion_date type="Anticipated">February 2021</completion_date>
  <primary_completion_date type="Anticipated">February 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Patient medical files</measure>
    <time_frame>1 month</time_frame>
    <description>ABO blood type distribution will be different in COVID-19</description>
  </primary_outcome>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>COVID-19 Infection</condition>
  <eligibility>
    <study_pop>
      <textblock>
        A retrospective multicenter trial in five major hospitals in Turkey to determine whether&#xD;
        ABO and Rh blood types carry any risk/beneficial factor among children with COVID-19&#xD;
        infection.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  The study period consisted between March 2020 and December 2020&#xD;
&#xD;
          -  Children with a documented positive COVID-19 nasal smear real-time&#xD;
             reverse-transcriptase polymerase chain reaction (PCR) assay were included.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients who had a past medical history of any chronic illness (related to&#xD;
             respiratory, cardiology, immunology, neurology, metabolic, etc) were excluded.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Month</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ali̇ Özdemi̇r, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mersi̇n Şehi̇r Eği̇ti̇m Ve Araşti̇rma Hastanesi̇</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ali̇ Özdemi̇r</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mersi̇n Şehi̇r Eği̇ti̇m Ve Araşti̇rma Hastanesi̇</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ali̇ Özdemi̇r, MD</last_name>
    <phone>03242251000</phone>
    <email>aliozdemir@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Mersin City Training &amp; Research Hospital</name>
      <address>
        <city>Mersi̇n</city>
        <zip>33240</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ali̇ Özdemi̇r, MD</last_name>
      <phone>03242251000</phone>
      <email>aliozdemir@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>December 22, 2020</study_first_submitted>
  <study_first_submitted_qc>December 23, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 24, 2020</study_first_posted>
  <last_update_submitted>January 30, 2021</last_update_submitted>
  <last_update_submitted_qc>January 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mersin Training and Research Hospital</investigator_affiliation>
    <investigator_full_name>Ali Özdemir</investigator_full_name>
    <investigator_title>Assoc Prof Ali Özdemir</investigator_title>
  </responsible_party>
  <keyword>COVID-19</keyword>
  <keyword>ABO blood group</keyword>
  <keyword>infection risk</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

